Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group.

被引：0
|
作者：
Gogas, H [1 ]
Polyzos, A [1 ]
Tsoutsos, D [1 ]
Panagiotou, P [1 ]
Iconomou, T [1 ]
Papadopoulos, S [1 ]
Papadopoulos, O [1 ]
Agarwala, S [1 ]
Stavrinidis, I [1 ]
Fountzilas, G [1 ]
机构：
[1] HeCOG Data Off, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：723S / 723S
页数：1
相关论文
共 50 条
  • [41] Irinotecan and oxaliplatin combination, as second-line treatment, in fluoropyrimidine-pretreated advanced colorectal cancer. A phase II study by the hellenic cooperative oncology group (HeCOG)
    Timotheadou, E
    Papakostas, P
    Tsavdaridis, D
    Basdanis, G
    Kalofonos, H
    Aravantinos, G
    Bafaloukos, D
    Fountzilas, G
    TUMORI JOURNAL, 2005, 91 (04): : 309 - 313
  • [42] The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: A phase II feasibility study conducted by the Hellenic Cooperative Oncology Group
    Samelis, GF
    Kalofonos, H
    Adamou, A
    Kosmides, P
    Skarlos, D
    Aravantinos, G
    Kiamouris, C
    Adimchi, O
    Fountzilas, G
    Dimopoulos, AM
    UROLOGY, 2005, 66 (02) : 382 - 385
  • [43] Cisplatin, dacarbazine, and fotemustine plus interferon α in patients with advanced malignant melanoma -: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group
    Daponte, A
    Ascierto, PA
    Gravina, A
    Melucci, MT
    Palmieri, G
    Comella, P
    Cellerino, R
    DeLena, M
    Marini, G
    Comella, G
    CANCER, 2000, 89 (12) : 2630 - 2636
  • [44] Updated results of a randomized phase II study comparing two schedules of temozolomide in combination with sorafenib in patients with advanced melanoma
    Amaravadi, R.
    Schuchter, L. M.
    McDermott, D. F.
    Kramer, A.
    Giles, L.
    Troxel, A. B.
    Medina, C. A.
    Nathanson, K. L.
    O'Dwyer, P. J.
    Flaherty, K. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study
    Sgouros, Joseph
    Aravantinos, Gerasimos
    Koliou, Georgia-Angeliki
    Pentheroudakis, George
    Zagouri, Flora
    Psyrri, Amanda
    Lampropoulou, Dimitra Ioanna
    Demiri, Stamatina
    Pectasides, Dimitrios
    Razis, Evangelia
    Fountzilas, George
    Samantas, Epaminontas
    ANTICANCER RESEARCH, 2020, 40 (02) : 929 - 938
  • [46] Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology
    Borbath, I.
    Ceratti, A.
    Verslype, C.
    Demols, A.
    Delaunoit, T.
    Laurent, S.
    Deleporte, A.
    Vergauwe, P.
    Van Maanen, A.
    Sempoux, C.
    Van Cutsem, E.
    Van Laethem, J. L.
    ANNALS OF ONCOLOGY, 2013, 24 (11) : 2824 - 2829
  • [47] Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: A phase II study of the Belgian Group of Digestive Oncology
    Borbath, I.
    Cerattli, A.
    Verslype, C.
    Demols, A.
    Delaunoit, T.
    Deleporte, A.
    Laurent, S. E.
    Vergauwe, P.
    Van Cutsem, E.
    Van Laethem, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [48] Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer - A hellenic cooperative oncology group study
    Pavlidis, N
    Nicolaides, C
    Athanassiadis, A
    Beriatou, K
    Skarlos, D
    Giannakakis, T
    Kosmidis, P
    Karvounis, N
    Fountzilas, G
    ONCOLOGY, 1996, 53 (02) : 159 - 162
  • [49] Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298) - A trial of the Eastern Cooperative Oncology Group
    Shepard, RC
    Levy, DE
    Berlin, JD
    Stuart, K
    Harris, JE
    Aviles, V
    Thomas, JP
    Benson, AB
    ONCOLOGY, 2004, 66 (04) : 303 - 309
  • [50] Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer. A phase II multicenter study by the Hellenic Cooperative Oncology Group
    Xiros, Nikolaos
    Economopoulos, Theofanis
    Samelis, George
    Papacostas, Pavlos
    Efstathiou, Eleni
    Onyenadum, Adimchi
    Skarlos, Dimosthenis
    Bamias, Aristotelis
    Gogas, Helen
    Kosmidis, Paris
    ANNALS OF ONCOLOGY, 2004, 15 : 241 - 241
12345